Biotech company Amgen to buy drug firm Horizon
Biotechnology giant Amgen is spending more than $26 billion to dive deeper into rare-disease treatments with a deal for drugmaker Horizon Therapeutics.
More from Arkansas Business
Arkansas Democratic Gazette | Business
$60 million Riggs facility to generate 75 jobs, open in 2027
Arkansas Business
•
19h ago
Talk Business Arkansas
Inflation expected to push holiday sales above $1 trillion
Arkansas Business
•
1d ago
Talk Business Arkansas
Rogers to vote on $457 million bond for street, park projects
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Arkansas Agriculture Hall of Fame accepting nominations
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
J.B. Hunt Transport Services Inc. reports $172.4 million quarterly profit
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Rogers-based America's Car-Mart gets seventh extension on loan terms from original Sept. 7 deadline
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Simmons First National reports $47.1 million third quarter profit
Arkansas Business
•
1d ago
